INDV — Indivior Pharmaceuticals Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Indivior Pharmaceuticals Inc (INDV), worth $172.66M combined. Over the quarter 3 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Madison Avenue | $117.94M | 5.10% | -33.4% |
| Gendell Jeffrey | $44.98M | 0.41% | NO CHANGE |
| Navellier | $7.13M | 0.57% | +29.6% |
| Quadrature | $1.59M | 0.01% | +56.9% |
| Persistent | $1.02M | 0.32% | +38.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.